The upcoming panel at the AAAS Annual Meeting aims to shed light on a groundbreaking opportunity in public health: the human exposome. Experts will delve into three pivotal aspects: the revolutionary potential of exposomics research, strategies for establishing a global network, and practical solutions to address scientific and policy challenges.
Prof. Thomas Hartung from Johns Hopkins University, who is organizing the panel, highlighted the ambitious nature of this initiative. "We aim to create significant impacts rather than mere ripples. Our committee has diligently worked over the past nine months, and the growing interest leading to concrete events and commitments is remarkable. We have exciting news to share, including three examples of collaboration with national governments, scientific institutions, and major organizations," he stated.
This event is scheduled for February 14th, 2026, at the Phoenix Convention Center, from 10:00 AM to 11:00 AM MST, and is open to accredited press members attending the AAAS Annual Meeting. Journalists and researchers keen on major public health initiatives and international collaboration are encouraged to participate and gain insights from leaders in this rapidly evolving field.
The Human Exposome Project: Shaping the Future of Medicine
The Human Exposome Project aspires to match, if not surpass, the ambitions of the Human Genome Project. While the latter revolutionized our understanding of genetics, it only addressed a fraction of the disease puzzle, with genes accounting for merely 10-20% of disease risk. In contrast, various biological, chemical, and environmental factors could influence up to 80% of health outcomes.
Although the significance of these exposures is substantial, coordinated efforts to investigate them have been slow to materialize. However, this is changing. Newly established regional chapters and working groups are enhancing exposomics research by integrating artificial intelligence, advanced sensor technologies, metabolomics, and big data analytics. These collaborative teams are forging partnerships to translate scientific findings into policies that benefit entire populations.
This initiative aligns with ongoing global research endeavors while dynamically expanding and yielding impactful results. Organizers acknowledge the necessity of weaving complex scientific insights into policymaking, particularly concerning emerging and sometimes contentious technologies. A bottom-up approach that engages citizens and policymakers is fundamental to the project's success. Advocates assert that research must focus on how combined exposures affect health, whether addressing childhood autism and asthma or regulating microplastics and pesticides.
South Africa's Role in a Pan-African Exposome Network
On December 1st, 2025, during the Science Forum South Africa, the South African government fostered exposome collaboration with national and pan-African experts to explore the feasibility of a continent-wide exposome network. Senior officials from the Department of Science, Technology and Innovation engaged in discussions about the initiative, building on South Africa's previous involvement in the Human Exposome Project launch in May 2025 in Washington D.C.
A significant outcome of the Pretoria gathering was the commitment of pan-African experts to collaborate with Global Exposome Forum working groups and participate in thematic meetings globally. Improving health data reporting systems emerged as an immediate priority, with a follow-up workshop planned for December 2026, marking a year since the initial meeting. The Science Diplomacy Capital for Africa has also expressed its willingness to host the pan-African exposome network.
Integrating Science Advice into Policy
Prof. Rémi Quirion, President of the International Network for Governmental Science Advice (INGSA), has actively supported exposomics and its international consortium. INGSA organized a policy-focused panel during the May 2025 meeting in Washington, featuring prominent scientists and leaders from organizations like UNESCO and WHO.
Since then, INGSA has facilitated discussions on integrating 'exposomethics' into policymaking with the Global Exposome Forum. Another significant session is planned for April 29th, 2026, at the Global Exposome Summit in Sitges, Spain. INGSA has also agreed to formalize collaboration with GEF and its extensive network to enhance engagement with science advisory systems worldwide.
On December 8th, 2025, the Global Exposome Forum launched a partnership with the Human Cell Atlas and UNESCO, which includes a series of virtual town halls on various topics, including genomics and science policy. A follow-up session is expected to take place in Paris on March 3rd, 2026, to prepare for a Memorandum of Understanding between UNESCO and the Global Exposome Forum.
Global Expansion and Upcoming Summit
Worldwide momentum continues to grow, with regional chapters being set up in Latin America, the Caribbean, and Southeast Asia. In Europe, the European Exposome Forum is organizing the Global Exposome Summit in Sitges, Spain, from April 27-29, 2026. Early registration has surpassed expectations, promising an event featuring leading figures in health science, artificial intelligence, and innovative policymaking.
Collaboration and Digital Platforms
Central to the Forum's strategy is the establishment of exposome-focused working groups. These member-driven teams address urgent scientific and policy questions, fostering collaboration among industry, government, academia, and civil society through a dedicated digital platform for communication and document sharing.
These working groups are fundamental to the Global Exposome Forum's structure, embodying its grassroots philosophy while facilitating extensive coordination across sectors and borders.
From Concept to Reality
These developments mark a transition from planning to action. Through public-private partnerships, international collaboration, and shared research resources, the Global Exposome Forum is poised to transform exposomics from a nascent idea into a powerful influence in public health and modern medicine.
